Pinnacle Associates
OPHI icon

Pinnacle Associates’s CollPlant Biotechnologies OPHI Stock Holding History

Pinnacle Associates’s Portfolio OPHI Stock Details OPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$268K Sell
70,960
-2,206
-3% -$7.6K ﹤0.01% 830
2026
Q2 		$255K Buy
73,166
+18,143
+33% +$69.9K ﹤0.01% 858
2026
Q1 		$295K Sell
55,023
-696
-1% -$7.02K ﹤0.01% 807
2025
Q4 		$780K Buy
55,719
+5,000
+10% +$102K 0.01% 566
2025
Q3 		$1.36M Hold
50,719
– – 0.02% 458
2025
Q2 		$690K Buy
50,719
+1,800
+4% +$37.3K 0.01% 570
2025
Q1 		$1.26M Sell
48,919
-50
-0.1% -$1.76K 0.02% 453
2024
Q4 		$1.76M Buy
48,969
+2,158
+5% +$87.7K 0.02% 390
2024
Q3 		$2.99M Sell
46,811
-9,625
-17% -$471K 0.05% 297
2024
Q2 		$2.8M Buy
56,436
+3,390
+6% +$188K 0.04% 314
2024
Q1 		$2.84M Buy
53,046
+6,235
+13% +$337K 0.04% 321
2023
Q4 		$2.99M Sell
46,811
-1,020
-2% -$55.8K 0.05% 300
2023
Q3 		$2.66M Sell
47,831
-634
-1% -$41.9K 0.05% 311
2023
Q2 		$3.95M Buy
+48,465
New +$3.53M 0.07% 258

Other funds holding OPHI

St. Denis J. Villere & Co
St. Denis J. Villere & Co New Orleans, Louisiana $775M AUM 13.27% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Parkside Financial Bank & Trust
Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Strive Financial Group
Strive Financial Group Carmel, Indiana $316M AUM 17.91% 1-Year Est. Return

Pinnacle Associates's OPHI Position: Q3 2026 in Review

Pinnacle Associates reduced its CollPlant Biotechnologies (OPHI) stake by 3% in Q3 2026, selling an estimated $7.6K and leaving 70,960 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Pinnacle Associates first reported a position in OPHI in Q2 2023 and has held it in 14 quarters since. The position peaked at $3.95M in Q2 2023. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

  • Pinnacle Associates held 70,960 shares of CollPlant Biotechnologies worth $268K as of Q3 2026.
  • Pinnacle Associates sold 2,206 CollPlant Biotechnologies shares in Q3 2026, an estimated $7.6K.
  • CollPlant Biotechnologies made up ﹤0.01% of Pinnacle Associates's portfolio in Q3 2026, its #830 holding.
  • Pinnacle Associates first reported a position in CollPlant Biotechnologies in Q2 2023 and has held it in 14 quarters since.
  • Pinnacle Associates's CollPlant Biotechnologies position peaked at $3.95M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.